The causality of gut microbiota on onset and progression of sepsis: a bi-directional Mendelian randomization analysis

被引:4
|
作者
Gao, Yuzheng [1 ]
Liu, Lidan [1 ]
Cui, Yuning [1 ]
Zhang, Jiaxin [1 ]
Wu, Xiuying [1 ]
机构
[1] China Med Univ, ShengJing Hosp, Dept Anesthesia, Shenyang, Liaoning, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
causal relationship; genetics; gut microbiota; Mendelian randomization; sepsis; CHAIN FATTY-ACIDS; RECEPTOR-IIB-DEFICIENT; INTESTINAL MICROBIOTA; SEPTIC SHOCK; MORTALITY; COLITIS; MICE; BACTERIA; HEALTH; LUPUS;
D O I
10.3389/fimmu.2024.1266579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Several observational studies have proposed a potential link between gut microbiota and the onset and progression of sepsis. Nevertheless, the causality of gut microbiota and sepsis remains debatable and warrants more comprehensive exploration.Methods We conducted a two-sample Mendelian randomization (MR) analysis to test the causality between gut microbiota and the onset and progression of sepsis. The genome-wide association study (GWAS) summary statistics for 196 bacterial traits were extracted from the MiBioGen consortium, whereas the GWAS summary statistics for sepsis and sepsis-related outcomes came from the UK Biobank. The inverse-variance weighted (IVW) approach was the primary method used to examine the causal association. To complement the IVW method, we utilized four additional MR methods. We performed a series of sensitivity analyses to examine the robustness of the causal estimates.Results We assessed the causality of 196 bacterial traits on sepsis and sepsis-related outcomes. Genus Coprococcus2 [odds ratio (OR) 0.81, 95% confidence interval (CI) (0.69-0.94), p = 0.007] and genus Dialister (OR 0.85, 95% CI 0.74-0.97, p = 0.016) had a protective effect on sepsis, whereas genus Ruminococcaceae UCG011 (OR 1.10, 95% CI 1.01-1.20, p = 0.024) increased the risk of sepsis. When it came to sepsis requiring critical care, genus Anaerostipes (OR 0.49, 95% CI 0.31-0.76, p = 0.002), genus Coprococcus1 (OR 0.65, 95% CI 0.43-1.00, p = 0.049), and genus Lachnospiraceae UCG004 (OR 0.51, 95% CI 0.34-0.77, p = 0.001) emerged as protective factors. Concerning 28-day mortality of sepsis, genus Coprococcus1 (OR 0.67, 95% CI 0.48-0.94, p = 0.020), genus Coprococcus2 (OR 0.48, 95% CI 0.27-0.86, p = 0.013), genus Lachnospiraceae FCS020 (OR 0.70, 95% CI 0.52-0.95, p = 0.023), and genus Victivallis (OR 0.82, 95% CI 0.68-0.99, p = 0.042) presented a protective effect, whereas genus Ruminococcus torques group (OR 1.53, 95% CI 1.00-2.35, p = 0.049), genus Sellimonas (OR 1.25, 95% CI 1.04-1.50, p = 0.019), and genus Terrisporobacter (OR 1.43, 95% CI 1.02-2.02, p = 0.040) presented a harmful effect. Furthermore, genus Coprococcus1 (OR 0.42, 95% CI 0.19-0.92, p = 0.031), genus Coprococcus2 (OR 0.34, 95% CI 0.14-0.83, p = 0.018), and genus Ruminiclostridium6 (OR 0.43, 95% CI 0.22-0.83, p = 0.012) were associated with a lower 28-day mortality of sepsis requiring critical care.Conclusion This MR analysis unveiled a causality between the 21 bacterial traits and sepsis and sepsis-related outcomes. Our findings may help the development of novel microbiota-based therapeutics to decrease the morbidity and mortality of sepsis.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Gut microbiota, circulating inflammatory proteins and sepsis: a bi-directional Mendelian randomization study
    Li, Zuming
    Lin, Liangcai
    Kong, Yunqi
    Feng, Jieni
    Ren, Xiaolei
    Wang, Yushi
    Chen, Xueru
    Wu, Siyi
    Yang, Rongyuan
    Li, Jiqiang
    Liu, Yuntao
    Lu, Yue
    Chen, Jiankun
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [2] Gut microbiota and epigenetic age acceleration: a bi-directional Mendelian randomization study
    Xu, Han
    Li, Ouyang
    Kim, Dayoung
    Bao, Zhijun
    Yang, Fan
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [3] The causality between gut microbiome and liver cirrhosis: a bi-directional two-sample Mendelian randomization analysis
    Xiao, Qing-Ao
    Yang, Yun-Fei
    Chen, Lin
    Xie, Ying-Chun
    Li, Hai-Tao
    Fu, Zhi-Gang
    Han, Qiang
    Qin, Jia
    Tian, Jie
    Zhao, Wen-Jiang
    Cai, Fei
    Hu, Yin-Tao
    Ai, Lin-Feng
    Li, Chao
    Chen, Xu-Ying
    Wang, Decheng
    Tan, Yu-Yan
    Xia, Xuan
    Zhang, Xiao-Lin
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [4] Assessing causality between frailty and lung cancer: A bi-directional Mendelian randomization analysis
    Fang, Chuangsen
    Li, Yanming
    Weng, Bingxuan
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [5] Genetically proxied gut microbiota, gut metabolites with risk of epilepsy and the subtypes: A bi-directional Mendelian randomization study
    Ouyang, Yuzhen
    Chen, Yu
    Wang, Ge
    Song, Yanmin
    Zhao, Haiting
    Xiao, Bo
    Yang, Zhuanyi
    Long, Lili
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [6] The relationship between gut microbiota and insomnia: a bi-directional two-sample Mendelian randomization research
    Li, Yan
    Deng, Qingqing
    Liu, Zhanli
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [7] Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study
    Su, Qing
    Jin, Chen
    Bo, Zhiyuan
    Yang, Yi
    Wang, Jingxian
    Wang, Juejin
    Zhou, Junxi
    Chen, Yaqing
    Zeng, Hao
    Chen, Gang
    Wang, Yi
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [8] Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study
    Kong, Youqian
    Liu, Shaoxuan
    Wang, Xiaoyu
    Qie, Rui
    MEDICINE, 2024, 103 (13) : E37628
  • [9] The causal relationship between gut microbiota and diabetic neuropathy: a bi-directional two-sample Mendelian randomization study
    Xie, Long
    Gan, Wen
    Cai, Guangrong
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [10] The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study
    Zhong, Yun
    Wang, Fan
    Meng, Xin
    Zhou, Lei
    FRONTIERS IN IMMUNOLOGY, 2024, 15